Trulieve Earnings + Call Notes
U.S. canna leader shares Q225 results.
$302 M Revs; est. $302M
$111M AEBITDA; est. $102.6M
$183 M GP; est. $181.1M
$52.6 M OI; est. $50.5M
60.6 % GM; est. 59.9%
($14M) NI; est. ($15.8M)
($0.07 ) EPS; est. ($0.07)
$137M CFO and $108M FCF in the 1H25
Sold 12.5M+ branded products in Q2, +9% vs. last year
Cash at quarter end was $401M.
Management Commentary
"The team has made tremendous progress on our 2025 plan, focusing on customers, distribution, branded products and reform. With strong margins and cash flow, scaled operations, and flexibility across our platform, Trulieve is uniquely positioned as an industry leader." Kim Rivers, Trulieve CEO.
Call Notes + Observations
Keep reading with a 7-day free trial
Subscribe to Cannabis Confidential to keep reading this post and get 7 days of free access to the full post archives.